JPRN-UMIN000009214已完成2 期
Somatostatin (Sandostatin) Safety Study on Polycystic Kidney and Liver Disease: Phase II study - STOPCYST Phase II Safety Study
Department of Urology, School of Medicine, Kyorin University0 个研究点目标入组 4 人开始时间: 2012年12月15日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects who are unlikely to adequately comply with trial's procedure. 2) Pregnant or lactating woman. 3) Subjects with uncontrolled or severe diabetes. 4) Subjects with allergy to octreotide or chemicals with similar structure to octreotide. 5) Subjects with comorbidity which interfare clinical evaluation. 6) Subjects with gall bladder stone. 7) Subjects who have scheduled surgery during trial. 8) Subjects taking other experimental therapies.
研究者
相似试验
进行中（未招募）
1 期
Research on the effectiveness of octreotide in Gastric Antral Vascular Ectasia (GAVE)in patients with anemia.Gastric Antral Vascular Ectasia (also known as watermelon stomach)EUCTR2020-004075-41-NLRadboudumc12
招募中
不适用
Effectiveness of Somatostatin Analogues in patients with Gastric Antral Vascular Ectasia and symptomatic gastrointestinal bleeding: SAGAVE Pilot studyNL-OMON21472Radboudumc12
招募中
2 期
Effectiveness of Somatostatin Analogues in patients with Gastric antral vascular ectasia and symptomatic gastrointestinal bleeding: SAGAVE-trial1) Gastric Antral Vascular Ectasia. 2) Watermelon stomach.10017959NL-OMON49336Radboud Universitair Medisch Centrum14
进行中（未招募）
1 期
The effectiveness of Octreotide in hereditary hemorrhagic telangiectasia (a.k.a. Rendu-Osler-Weber disease) patients who suffer from gastrointestinal bleeding.EUCTR2018-004179-11-NLRadboudumc38
尚未招募
不适用
Onderzoek naar de effectiviteit van octreotide in hereditary hemorrhagic telangiectasia patiënten metdaarbij gastrointestinale bloedingen.NL-OMON25382Radboudumc38